Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Nancy E. Davidson(WinnMed), Ian E. Krop(Yale Cancer Center), Sarat Chandarlapaty(Memorial Sloan Kettering Cancer Center), Nancy U. Lin(Dana-Farber Cancer Institute), Aki Morikawa(Memorial Sloan Kettering Cancer Center), Maria Alice Franzoi(Institut Gustave Roussy), Jennie R. Crews(CancerCare Manitoba), Jane Perlmutter(Gemini Computers (United States)), Sarah Temin(Virginia Cancer Institute), Debra A. Patt(Texas Oncology), Naren Ramakrishna, Jeffrey J. Kirshner(American Society of Clinical Oncology), Carey K. Anders(Duke University)
Cited by 181
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k